Lymphoma Research Foundation
EIN 954335088 Public CharityAnnual Giving
$16.5M
120 grants · avg $2.8M/yr
public charity (Form 990), grant-level detail not in 990-PF database
$1M+/yr
mid-tier
capacity
$105K
typical big bets · $10K–$146K
grant size
41%
supporter · 20/49 multi-year
repeat
49
Distinct Recipients
Application Information
Accepts Unsolicited Proposals
Unknown
Grant Size Distribution
Based on 120 grants on record
Minimum
$10K
25th Pctl
$10K
Median
$105K
Average
$138K
75th Pctl
$146K
Maximum
$975K
Geographic Distribution
Texas Counties Served
6.7% of US grants
· Rank #5 of 23 states
$525K across
8 grants
1 of 254 counties
Top 1 counties
- 1 Harris
Grants Awarded (120 total)
| Purpose | ||||
|---|---|---|---|---|
| Mayo Clinic Rochester Mn | Minneapolis, MN | $975,000 | FOLLICULAR | 2023 |
| Weill Medical College of Cornell University | New York, NY | $855,000 | FOLLICULAR | 2023 |
| Icahn School of Medicine at Mount Sinai | New York, NY | $750,000 | FOLLICULAR | 2023 |
| Stanford University | Los Angeles, CA | $750,000 | FOLLICULAR | 2023 |
| Mayo Clinic | Minneapolis, MN | $750,000 | Follicular | 2022 |
| Washington University in StLouis | St Louis, MO | $750,000 | Follicular | 2022 |
| Massachusetts General Hospital | Boston, MA | $750,000 | Follicular | 2022 |
| Memorial Sloan Kettering Cancer Center | New York, NY | $750,000 | Follicular | 2022 |
| Sloan Kettering Institute for Cancer Research | New York, NY | $450,000 | CDA | 2022 |
| The Trustees of the University of Pennsylvania | Philadelphia, PA | $330,000 | CDA & FELLOWSHIP | 2023 |
| Hlee Moffitt Cancer Center & Research Institute | Tampa, FL | $250,000 | New Therapeutic Vulnerabilities for Ibrutinib Resistance Mantle Cell Lymphoma (MCL). | 2018 |
| Duke University Medical Center | Durham, NC | $250,000 | Genome predictors of response in mantle cell lymphoma. | 2018 |
| Memorial Sloan Kettering Cancer Center | New York, NY | $235,000 | CDA & MENTORING | 2023 |
| Univeristy of North Carolina at Chapel Hill | Chapel Hill, NC | $225,000 | , | 2020 |
| University of Texas MD Anderson Cancer Center | Houston, TX | $225,000 | , | 2020 |
| University of Washington | Seattle, WA | $225,000 | Optimizing Checkpoint-Inhibitor Combinations in the Management of Classic Hodgkin Lymphoma | 2020 |
| Children Research Institute | Washington, DC | $225,000 | Developing syngergistic immunetherapies for high risk Hodgkin Lymphoma. | 2018 |
| Massachusetts General Hospital | Boston, MA | $225,000 | Eradicating minimum residual disease | 2018 |
| St Jude Children'S Research Hospital Inc | Memphis, TN | $225,000 | CAREER DEVELOPMENT AWARD | 2021 |
| Emory University - Winship Cancer Institute | Atlanta, GA | $225,000 | CAREER DEVELOPMENT AWARD | 2021 |
| Dana-Farber Cancer Institute | Boston, MA | $225,000 | CAREER DEVELOPMENT AWARD | 2021 |
| University of Pennsylvania | Philadelphia, PA | $225,000 | CAREER DEVELOPMENT AWARD | 2021 |
| The University of Utah | Salt Lake City, UT | $225,000 | CDA | 2022 |
| Miller School of Medicine of the Univ0 of Miami | Atlanta, GA | $225,000 | CDA | 2022 |
| University of North Carolina at Chapel Hill | Chapel Hill, NC | $225,000 | Career Development Award - A new, augmented CAR-T cell targeting koppa light chains on B cell lymphomas for clinical... | 2019 |
Looking for more funders like Lymphoma Research Foundation? Browse the full funder database. Search 178,000+ foundations by state, type, and giving size.
Want to compare open opportunities instead? Browse the grant database for active grants from federal, state, foundation, and corporate funders.